|
V.TLT
|
You forget that this trial is just for safety, not for efficacy and not using...
|
|
V.TLT
|
until January. Just remember what we're looking at here: Phase 1b HUMAN...
|
|
T.SZLS
|
Not IXDG board... Not interested
|
|
V.TLT
|
Depends on who your broker is, but if your bid is for more than 20k (I think)...
|
|
V.TLT
|
Well, you came out of a "poof" on Nov 29, won't be surprised if...
|
|
V.TLT
|
We just leave it up to you, nacrbk2, to balance off the intelligent posts.
|
|
V.TLT
|
I hear you Oilminerdeluxe. I find it good to bear in mind that most of what...
|
|
T.SZLS
|
I'd just like to say that I, too, don't discriminate against dense...
|
|
V.TLT
|
...any objection to posting your AGM summaries on Twitter?
|
|
V.TLT
|
...at .275. The market hears about a lot of clinical trials, so no surprise...
|
|
T.SZLS
|
This is the GEN board. We talk about GEN here - or we should :)
|
|
T.SZLS
|
Pretty casual use of "freefall." I've seen freefalls and so...
|
|
T.SZLS
|
I'm still in the building phase, myself :)
|
|
T.SZLS
|
Not a bad policy, Warren Buffet said, "Diversificationmay preserve...
|
|
T.SZLS
|
Sorry Nailbiter, please disregard my last post, just getting tired of the...
|
|
T.SZLS
|
Nailbiter1, if you spent half as much time researching your stocks as you do...
|
|
T.SZLS
|
Agreed, I'm always a bit leery about news or halts on a Friday. Hoping...
|
|
V.RHT
|
Ya, 2.3 million traded today and in the green, that's obviously bad for...
|
|
T.SZLS
|
no joy yet, bring it down, baby.
|
|
T.SZLS
|
Skier59, relax. Name calling, really? Can we focus on GEN? You never suggest...
|